Additive effect of Tadalafil and Simvastatin on monocrotaline-induced pulmonary hypertension rats

By Zhang Wei-Hua   Liu Chun-Ping   Zhang Yun-Jian   Ji Ying-Qun   Lu Wei-Xuan   Zeng Qiang  

Scandinavian Cardiovascular Journal, Vol. 46, Iss. 6, 2012-12 ,pp. : 374-380

Informa Healthcare

Access to resources Recommend Favorite

Erythropoietin, but Not Asialoerythropoietin or Carbamyl-Erythropoietin, Attenuates Monocrotaline-Induced Pulmonary Hypertension in Rats

By Ikarashi Noboru   Toba Ken   Kato Kiminori   Ozawa Takuya   Oda Masato   Takayama Tsugumi   Kobayashi Hironori   Yanagawa Takao   Hanawa Haruo   Suzuki Tomoyasu   Nakazawa Mikio   Nomoto Minoru   Asami Fuyuki   Higuchi Masato   Saito Hideki   Aizawa Yoshifusa  

Clinical and Experimental Hypertension, Vol. 34, Iss. 8, 2012-12 ,pp. : 575-581

Informa Healthcare

Access to resources Recommend Favorite

Assessment of the Endothelial Functions in Monocrotaline-induced Pulmonary Hypertension

By Sirmagul Basar  

Clinical and Experimental Hypertension, Vol. 35, Iss. 3, 2013-05 ,pp. : 220-227

Informa Healthcare

Access to resources Recommend Favorite

Simvastatin protects against the development of monocrotaline-induced pulmonary hypertension in rats via a heme oxygenase-1–dependent pathway

By Zhang Wei-hua   Zhang Yun-jian   Liu Chun-ping   Yu Bing-xiang   Lu Wei-xuan  

Experimental Lung Research, Vol. 37, Iss. 8, 2011-09 ,pp. : 492-499

Informa Healthcare

Access to resources Recommend Favorite

Development of Monocrotaline-Induced Pulmonary Hypertension Is Attenuated by a Serotonin Receptor Antagonist

By Miyata M.   Ito M.   Sasajima T.   Ohira H.   Sato Y.   Kasukawa R.  

Lung, Vol. 178, Iss. 2, 2000-03 ,pp. : 63-73

Springer Publishing Company

Access to resources Recommend Favorite